Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMC 2138424)

Published in J Exp Med on December 01, 1967

Authors

R D Guttmann, C B Carpenter, R R Lindquist, J P Merrill

Articles citing this

Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16

Antigen-induced release of slow reacting substance of anaphylaxis (SRS-A rat) in rats prepared with homologous antibody. J Exp Med (1968) 1.77

Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61

Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53

Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19

Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats. Clin Exp Immunol (1969) 1.06

Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin. J Clin Invest (1971) 1.05

The effect of heterologous anti-lymphocyte serum on lymphocytes of thymus and marrow origin. J Exp Med (1970) 1.04

The effects of ALG on the murine immune response to sheep erythrocytes. Immunology (1972) 1.01

Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation. Clin Exp Immunol (1971) 0.94

The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin. Clin Exp Immunol (1971) 0.90

Further studies on the effect of anti-lymphocytic antibody on humoral antibody formation. Clin Exp Immunol (1968) 0.89

Suppression of primary immune response by heterologous anti-lymphocyte sera. Immunology (1978) 0.85

A study of the potential nephrotoxicity of heterologous anti-lymphocyte serum. Clin Exp Immunol (1970) 0.83

Mechanism of complement action in rosette inhibition and lymphocytotoxicity of antilymphocyte serum. Immunology (1972) 0.81

Prolongation of renal allotransplant in the rat by antigen-antibody mixture. Ann R Coll Surg Engl (1973) 0.75

EFFECT OF DONOR PRETREATMENT WITH CYCLOPHOSPHAMIDE ON THE MECHANICAL PERFORMANCE OF THE ISOLATED HEART. Cardiovasc Dis (1976) 0.75

Articles cited by this

Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol (1961) 113.20

THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56

[A micro-method of immuno-electrophoresis]. Int Arch Allergy Appl Immunol (1955) 52.23

Application of a microtechnique to viral serological investigations. J Immunol (1962) 51.33

A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66

Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation. J Cell Biol (1963) 41.10

QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol (1965) 16.97

Studies on antibody production. I. A method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit. J Exp Med (1955) 16.36

Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys (1960) 13.40

A simple chromatographic method for preparation of gamma globulin. Proc Soc Exp Biol Med (1960) 11.02

Dissociation of human serum macroglobulins. Science (1957) 10.94

Antigen elimination from the blood as an early manifestation of the immune response. J Immunol (1951) 8.92

A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY. Virology (1963) 8.83

Antibody formation. I. The suppression of antibody formation by passively administered antibody. J Exp Med (1961) 8.06

Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1966) 7.56

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION. J Immunol (1965) 7.06

Localization of the nephrotoxic antigen within the isolated renal glomerulus. AMA Arch Pathol (1951) 6.61

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05

Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59

IN VIVO BEHAVIOR OF I-FIBRINOGEN. J Clin Invest (1963) 5.03

Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol (1966) 4.49

THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med (1965) 3.87

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83

THE EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Ann N Y Acad Sci (1964) 3.79

Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76

EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature (1963) 3.65

Immunological studies on the rat thymectomized in adult life. Immunology (1965) 3.17

Allograft survival: effect of antiserums to thymus glands and lymphocytes. Science (1965) 2.45

Effect of antilymphocytic serum on the survival of renal homotransplants in dogs. Transplantation (1966) 2.38

Enhancement of antibody formation by whole body x-radiation. J Exp Med (1963) 2.22

Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol (1955) 2.16

EXPERIMENTAL GLOMERULONEPHRITIS. VI. THE AUTOLOGOUS PHASE OF NEPHROTOXIC SERUM NEPHRITIS. J Exp Med (1965) 2.14

A rapid method for localization of tissue structures or lesions for electron microscopy. J Biophys Biochem Cytol (1959) 1.82

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

MITOGENIC ACTION OF ANTILEUCOCYTE IMMUNE SERUM ON PERIPHERAL LEUCOCYTES IN VITRO. Lancet (1963) 1.59

STUDIES OF IMMUNE DESTRUCTION OF LYMPHOID TISSUE. I. LYMPHOCYTOTOXIC EFFECT OF RABBIT-ANTI-RAT-LYMPHOCYTE ANTISERUM. Transplantation (1964) 1.56

Stimulation of splenic antigen uptake and of antibody response in mice by India ink or other "blockading" agents. Immunology (1966) 1.33

An estimate of the number of histocompatibility loci in the rat. Proc Natl Acad Sci U S A (1962) 1.32

Synthetic polypeptide metabolism. 3. Degradation and organ localization of isomeric synthetic polypeptide antigens. J Immunol (1967) 1.28

Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22

Enhancement of antibody synthesis by 6-mercaptopurine. J Exp Med (1966) 1.22

The survival of homografts in mice pretreated with antisera to mouse tissue. Ann N Y Acad Sci (1957) 1.21

EXPERIMENTAL STUDIES UPON LYMPHOCYTES : II. THE ACTION OF IMMUNE SERA UPON LYMPHOCYTES AND SMALL THYMUS CELLS. J Exp Med (1917) 1.18

Nephritogenic properties of cross-reacting kidney-fixing antibodies to heart, spleen and muscle. J Immunol (1967) 1.11

Localization of I131-labeled antirat lymph node and kidney rabbit antibodies in the rat. J Immunol (1959) 0.95

Gamma globulin catabolism by the kidney. Tex Rep Biol Med (1965) 0.92

REACTIONS OF LOCALIZING ANTI-KIDNEY ANTIBODIES WITH TISSUES OF VARIOUS SPECIES. J Immunol (1965) 0.83

Measurement of renal function in the rat with single injection clearances. Am J Physiol (1967) 0.81

Articles by these authors

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90

The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet (1998) 5.25

The case for "presumed consent" in organ donation. International Forum for Transplant Ethics. Lancet (1998) 4.99

Should organs from patients in permanent vegetative state be used for transplantation? International Forum for Transplant Ethics. Lancet (1997) 4.04

Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34

Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48

Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43

Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33

Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14

Cytomegalovirus infection after renal allotransplantation. JAMA (1967) 2.08

Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06

Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med (1984) 2.03

Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01

The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92

Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85

Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83

Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med (1975) 1.82

Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med (1968) 1.80

Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74

Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70

Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69

Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes. Science (1968) 1.69

Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68

Absence of collagen deficiency in familial cerebral aneurysms. J Neurosurg (1989) 1.63

Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63

Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62

Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) (1969) 1.61

Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. Can Med Assoc J (1983) 1.52

Glomerulonephritis (third of three parts). N Engl J Med (1974) 1.52

Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51

Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med (1981) 1.49

Renal transplantation in the inbred rat. IX. Hematopoietic origin of an immunogenic stimulus of rejection. Transplantation (1969) 1.49

The role of antibodies in the rejection and enhancement of organ allografts.?7318. Adv Immunol (1976) 1.48

Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45

Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45

Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest (1978) 1.44

Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43

Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42

Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39

Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation (1997) 1.38

Enzyme replacement therapy by renal allotransplantation in Fabry's disease. N Engl J Med (1972) 1.38

The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med (1976) 1.33

Spontaneous diabetes mellitus syndrome in the rat. II. T lymphopenia and its association with clinical disease and pancreatic lymphocytic infiltration. J Immunol (1983) 1.33

Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron (1966) 1.33

Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection. J Exp Med (1986) 1.32

Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30

Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations. Tissue Antigens (1979) 1.29

Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29

Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28

Synthetic polypeptide metabolism. 3. Degradation and organ localization of isomeric synthetic polypeptide antigens. J Immunol (1967) 1.28

Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28

Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28

Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis (1993) 1.28

Reduction of immunogenicity of human cadaver renal allografts by donor pretreatment. Transplant Proc (1973) 1.24

The emotional impact of end-stage renal disease: importance of patients' perception of intrusiveness and control. Int J Psychiatry Med (1984) 1.23

Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22

Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22

Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22

Editoral: Cardiovascular disease in dialysis patients. N Engl J Med (1974) 1.20

Uremic pericarditis. Clinical features and management. Circulation (1968) 1.20

Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19

Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res (1998) 1.19

An immunosupressive site of action of heterologous antilymphocyte serum. Lancet (1967) 1.17

Effect of mercaptans and other agents on the human complement component beta-1c-globulin. Immunology (1966) 1.17

Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med (1973) 1.15

Renal transplantation in the inbred rat. II. An immunohistochemical study of acute allograft rejection. Am J Pathol (1968) 1.14

Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.13

Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13

Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol (1977) 1.12

Cellular immunity in the mouse. II. Correlation of in vivo and in vitro phenomena. Cell Immunol (1972) 1.12

Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences. Arch Intern Med (1973) 1.11

Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy. Arch Intern Med (1978) 1.10

Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. Transplantation (1979) 1.10

Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med (1995) 1.10

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A (1992) 1.10

Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages. J Exp Med (1984) 1.10

Cellular immunity in the mouse. I. In vitro lymphocyte reactivity. Cell Immunol (1972) 1.10

Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation (1997) 1.10

Role of indirect allorecognition in allograft rejection. Int Rev Immunol (1996) 1.10